Table 2.
Adjusted hazard of mortality for deceased donor transplantation by patient characteristics and center performance
Candidate Characteristic/Level | Center Performance at the Time of Listing | P Value for Interaction | ||
---|---|---|---|---|
Higher than Expected | As Expected | Lower than Expected | ||
All patients | 0.24 (0.21 to 0.27) | 0.32 (0.31 to 0.33) | 0.40 (0.35 to 0.45) | |
Race/ethnicity | ||||
Caucasian | 0.27 (0.23 to 0.32) | 0.33 (0.32 to 0.34) | 0.38 (0.32 to 0.45) | 0.50 |
African American | 0.18 (0.14 to 0.24) | 0.32 (0.30 to 0.33) | 0.38 (0.31 to 0.48) | |
Other | 0.21 (0.14 to 0.32) | 0.29 (0.27 to 0.30) | 0.45 (0.35 to 0.58) | |
Sex | ||||
Men | 0.24 (0.20 to 0.28) | 0.33 (0.31 to 0.34) | 0.42 (0.36 to 0.48) | 0.63 |
Women | 0.25 (0.20 to 0.31) | 0.30 (0.29 to 0.32) | 0.37 (0.30 to 0.45) | |
Body mass index | ||||
Obesea | 0.27 (0.21 to 0.34) | 0.33 (0.31 to 0.34) | 0.39 (0.32 to 0.48) | 0.33 |
Nonobesea | 0.24 (0.20 to 0.28) | 0.31 (0.30 to 0.32) | 0.41 (0.35 to 0.47) | |
Cause of ESRD | ||||
Diabetes | 0.24 (0.19 to 0.30) | 0.30 (0.29 to 0.31) | 0.42 (0.35 to 0.50) | 0.12 |
Other | 0.24 (0.20 to 0.28) | 0.33 (0.32 to 0.34) | 0.39 (0.34 to 0.46) | |
Primary insurance | ||||
Private | 0.22 (0.18 to 0.27) | 0.32 (0.30 to 0.33) | 0.35 (0.28 to 0.44) | 0.06 |
Nonprivate | 0.25 (0.21 to 0.29) | 0.32 (0.31 to 0.33) | 0.42 (0.37 to 0.48) | |
Age, yr | ||||
18–40 | 0.14 (0.08 to 0.23) | 0.27 (0.25 to 0.29) | 0.37 (0.26 to 0.53) | 0.01 |
41–60 | 0.23 (0.19 to 0.27) | 0.30 (0.29 to 0.31) | 0.35 (0.29 to 0.41) | |
>60 | 0.29 (0.24 to 0.36) | 0.35 (0.34 to 0.36) | 0.49 (0.41 to 0.59) | |
Educational attainment | ||||
College or morea | 0.24 (0.19 to 0.30) | 0.33 (0.31 to 0.34) | 0.35 (0.29 to 0.44) | 0.05 |
Less than collegea | 0.26 (0.22 to 0.31) | 0.31 (0.29 to 0.32) | 0.41 (0.35 to 0.48) |
Values depict the adjusted hazard ratio (95% confidence interval) of mortality for kidney transplantation relative to waitlisted patients adjusted for age, race, sex, body mass index, insurance type, panel-reactive antibody level, educational attainment, active status at listing (yes or no), primary versus retransplant status, primary diagnosis, and time to listing from ESRD onset.
Missing levels not included.